Vaso Corp
OTC:VASO
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Vaso Corp
OTC:VASO
|
30.4m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
199.4B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.2B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
145.6B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.9B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.1B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.6B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.5B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.7B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.8B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.4B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Vaso Corp
Glance View
Vaso Corp. engages in the healthcare equipment and information technology industries. The company is headquartered in Plainview, New York and currently employs 256 full-time employees. The firm's segments include IT, Professional sales service and Equipment. The IT segment operates through the Company's subsidiary, VasoTechnology, Inc., which is focused on healthcare IT and managed network technology service. The Professional sales service segment operates through the Company's subsidiary, Vaso Diagnostics, Inc. doing business as VasoHealthcare, which is focused on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. The Equipment segment is focused on designing, manufacturing, selling and servicing of medical devices, operating through the Company's subsidiary, VasoMedical, Inc., which in turn operates through Vasomedical Solutions, Inc. for domestic business and Vasomedical Global Corp. for international business, respectively.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Vaso Corp is 59.8%, which is below its 3-year median of 61.1%.
Over the last 3 years, Vaso Corp’s Gross Margin has increased from 59.1% to 59.8%. During this period, it reached a low of 59.1% on Jun 30, 2022 and a high of 62.4% on Dec 31, 2023.
